{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T08:01:18Z","timestamp":1774512078740,"version":"3.50.1"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,25]],"date-time":"2024-12-25T00:00:00Z","timestamp":1735084800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008688","name":"Cinvestav","doi-asserted-by":"publisher","award":["2022"],"award-info":[{"award-number":["2022"]}],"id":[{"id":"10.13039\/501100008688","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Humanidades, Ciencias y Tecnolog\u00edas","doi-asserted-by":"publisher","award":["CF-2023-G-231"],"award-info":[{"award-number":["CF-2023-G-231"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.virol.2024.110380","type":"journal-article","created":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T19:32:53Z","timestamp":1735068773000},"page":"110380","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Immunogenicity of a multivalent protein subunit vaccine based on non-glycosylated RBD antigens of SARS-cov-2 and its variants"],"prefix":"10.1016","volume":"603","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6144-1411","authenticated-orcid":false,"given":"Berenice","family":"Calder\u00f3n-P\u00e9rez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leandro Alberto","family":"N\u00fa\u00f1ez-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lady Laura","family":"Trejo-Ayala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00edctor Hugo","family":"Rosales-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjam\u00edn Emmanuel","family":"Ch\u00e1vez-\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brenda Yazm\u00edn","family":"Vargas-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Abrah\u00e1n","family":"Ram\u00edrez-Pool","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Ruiz-Medrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7366-7725","authenticated-orcid":false,"given":"Beatriz","family":"Xoconostle-C\u00e1zares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2024.110380_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115335","article-title":"Gopalakrishnan Nair B, Suravajhala R. Glycosylation in SARS-CoV-2 variants: a path to infection and recovery","volume":"206","author":"Aloor","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.virol.2024.110380_bib2","article-title":"Factors affecting vaccine attitudes influenced by the COVID-19 pandemic","volume":"11","author":"Altman","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.virol.2024.110380_bib3","article-title":"Relationship between endotoxin content in vaccine preclinical formulations and animal welfare: an extensive study on historical data to set an informed threshold","volume":"12","author":"Baffetta","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.virol.2024.110380_bib4","article-title":"Unglycosylated soluble SARS-CoV-2 receptor binding domain (RBD) produced in E. coli combined with the army liposomal formulation containing QS21 (ALFQ) elicits neutralizing antibodies against mismatched variants","volume":"11","author":"Balasubramaniyam","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.virol.2024.110380_bib5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bbrc.2021.04.056","article-title":"Dal Piaz F, Hochkoeppler A. Production in Escherichia coli of recombinant COVID-19 spike protein fragments fused to CRM197","volume":"558","author":"Bellone","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.virol.2024.110380_bib6","article-title":"A multi-disulfide receptor-binding domain (RBD) of the SARS-CoV-2 spike protein expressed in E. coli using a SEP-tag produces antisera interacting with the mammalian cell expressed spike (S1)","volume":"23","author":"Brindha","year":"2022","journal-title":"Protein. Int. J. Mol. Sci."},{"key":"10.1016\/j.virol.2024.110380_bib7","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/jps.22267","article-title":"Acceptable levels of endotoxin in vaccine formulations during preclinical research","volume":"100","author":"Brito","year":"2011","journal-title":"J. Pharmaceut. Sci."},{"key":"10.1016\/j.virol.2024.110380_bib8","doi-asserted-by":"crossref","first-page":"W402","DOI":"10.1093\/nar\/gkz297","article-title":"The PSIPRED protein analysis workbench: 20 years on","volume":"47","author":"Buchan","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.virol.2024.110380_bib9","doi-asserted-by":"crossref","DOI":"10.1093\/pnasnexus\/pgac062","article-title":"Abnormal antibodies to self-carbohydrates in SARS-CoV-2-infected patients","volume":"1","author":"Butler","year":"2022","journal-title":"PNAS Nexus"},{"key":"10.1016\/j.virol.2024.110380_bib10","first-page":"162","article-title":"SARS-CoV-2 variant biology: immune escape, transmission and fitness","volume":"21","author":"Carabelli","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.virol.2024.110380_bib11","article-title":"Adjuvants for COVID-19 vaccines","volume":"11","author":"Castrodeza-Sanz","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.virol.2024.110380_bib12","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1007\/s43440-022-00425-5","article-title":"Recent review of COVID-19 management: diagnosis, treatment and vaccination","volume":"74","author":"Chavda","year":"2022","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.virol.2024.110380_bib13","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jconrel.2024.01.017","article-title":"Protein subunit vaccines: promising frontiers against COVID-19","volume":"366","author":"Chavda","year":"2024","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.virol.2024.110380_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/biom11081072","article-title":"Platforms for production of protein-based vaccines: from classical to next-generation strategies","volume":"11","author":"Cid","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.virol.2024.110380_bib15","first-page":"1477","article-title":"Haematological and biochemical profile of balb-c mice","volume":"45","author":"de Sousa-Barbosa","year":"2017","journal-title":"Acta Sci. Vet."},{"key":"10.1016\/j.virol.2024.110380_bib16","doi-asserted-by":"crossref","DOI":"10.1007\/s00894-014-2278-5","article-title":"AllerTOP v.2 - a server for in silico prediction of allergens","volume":"20","author":"Dimitrov","year":"2014","journal-title":"J. Mol. Model."},{"key":"10.1016\/j.virol.2024.110380_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-020-00352-y","article-title":"A systematic review of SARS-CoV-2 vaccine candidates","volume":"5","author":"Dong","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.virol.2024.110380_bib18","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2105-8-4","article-title":"VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines","volume":"8","author":"Doytchinova","year":"2007","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.virol.2024.110380_bib19","author":"ECDC"},{"key":"10.1016\/j.virol.2024.110380_bib20","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.vacun.2023.08.002","article-title":"Delving into revolutionary SARS-CoV-2 vaccine approaches: molecular and virological examinations; principles of SARS-CoV-2 vaccine platform","volume":"25","author":"Edalat","year":"2024","journal-title":"Vacunas"},{"key":"10.1016\/j.virol.2024.110380_bib21","article-title":"Dynamics of antibody and T cell immunity against SARS-CoV-2 variants of concern and the impact of booster vaccinations in previously infected and infection-na\u00efve individuals","volume":"10","author":"Faas","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.virol.2024.110380_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.848054","article-title":"Combined subcutaneous-intranasal immunization with epitope-based antigens elicits binding and neutralizing antibody responses in serum and mucosae against PRRSV-2 and SARS-CoV-2","volume":"13","author":"Fragoso-Saavedra","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virol.2024.110380_bib23","doi-asserted-by":"crossref","unstructured":"Gasteiger E, Hoogland C, Gattiker A, Duvaud S, Wilkins MR, Appel RD, et al. Protein Analysis Tools on the ExPASy Server 571 571 from: the Proteomics Protocols Handbook Protein Identification and Analysis Tools on the ExPASy Server. n.d.","DOI":"10.1385\/1-59259-890-0:571"},{"key":"10.1016\/j.virol.2024.110380_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-021-00809-8","article-title":"The glycosylation in SARS-CoV-2 and its receptor ACE2","volume":"6","author":"Gong","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.virol.2024.110380_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/v13030392","article-title":"Sars-cov-2 variant of concern 202012\/01 has about twofold replicative advantage and acquires concerning mutations","volume":"13","author":"Grabowski","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.virol.2024.110380_bib26","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1080\/14760584.2023.2211153","article-title":"Advances in SARS-CoV-2 receptor-binding domain-based COVID-19 vaccines","volume":"22","author":"Guan","year":"2023","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.virol.2024.110380_bib27","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/elsc.202000106","article-title":"Purification and characterization of the receptor-binding domain of SARS-CoV-2 spike protein from Escherichia coli","volume":"21","author":"He","year":"2021","journal-title":"Eng. Life Sci."},{"key":"10.1016\/j.virol.2024.110380_bib28","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1093\/bioinformatics\/btx345","article-title":"Protein-Sol: a web tool for predicting protein solubility from sequence","volume":"33","author":"Hebditch","year":"2017","journal-title":"Bioinformatics"},{"key":"10.1016\/j.virol.2024.110380_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.927306","article-title":"A comprehensive review of the protein subunit vaccines against COVID-19","volume":"13","author":"Heidary","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.virol.2024.110380_bib30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","article-title":"Mechanisms of SARS-CoV-2 entry into cells","volume":"23","author":"Jackson","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.virol.2024.110380_bib31","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.virol.2024.110380_bib32","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nri778","article-title":"Effector and memory T-cell differentiation: implications for vaccine development","volume":"2","author":"Kaech","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.virol.2024.110380_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2022.113279","article-title":"Non-glycosylated SARS-CoV-2 RBD elicited a robust neutralizing antibody response in mice","volume":"506","author":"Ke","year":"2022","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.virol.2024.110380_bib34","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/0014-5793(90)80535-Q","article-title":"A semi-empirical method for prediction of antigenic determinants on protein antigens","volume":"276","author":"Kolaskar","year":"1990","journal-title":"FEBS Lett."},{"key":"10.1016\/j.virol.2024.110380_bib35","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41579-022-00713-0","article-title":"SARS-CoV-2 pathogenesis","volume":"20","author":"Lamers","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.virol.2024.110380_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25061290","article-title":"Enhancing the immune response of a nicotine vaccine with synthetic small \u201cnon-Natural\u201d peptides","volume":"25","author":"Le","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.virol.2024.110380_bib37","doi-asserted-by":"crossref","first-page":"W451","DOI":"10.1093\/nar\/gkz288","article-title":"GalaxyRefine2: simultaneous refinement of inaccurate local regions and overall protein structure","volume":"47","author":"Lee","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.virol.2024.110380_bib38","author":"Li"},{"key":"10.1016\/j.virol.2024.110380_bib39","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1002\/jps.21152","article-title":"Endotoxin limits in formulations for preclinical research","volume":"97","author":"Malyala","year":"2008","journal-title":"J. Pharmaceut. Sci."},{"key":"10.1016\/j.virol.2024.110380_bib40","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41579-023-00878-2","article-title":"The evolution of SARS-CoV-2","volume":"21","author":"Markov","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.virol.2024.110380_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.701501","article-title":"SARS-CoV-2 vaccines based on the spike glycoprotein and implications of new viral variants","volume":"12","author":"Mart\u00ednez-Flores","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virol.2024.110380_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/cells10061550","article-title":"The role of th17 response in COVID-19","volume":"10","author":"Martonik","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.virol.2024.110380_bib43","article-title":"Combination of recombinant proteins S1\/N and RBD\/N as potential vaccine candidates","volume":"11","author":"Mendoza-Ram\u00edrez","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.virol.2024.110380_bib44","article-title":"Recombinant antigens based on non-glycosylated regions from rbd sars-cov-2 as potential vaccine candidates against covid-19","volume":"9","author":"N\u00fa\u00f1ez-Mu\u00f1oz","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.virol.2024.110380_bib45","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/pro.3943","article-title":"UCSF ChimeraX: structure visualization for researchers, educators, and developers","volume":"30","author":"Pettersen","year":"2021","journal-title":"Protein Sci."},{"key":"10.1016\/j.virol.2024.110380_bib46","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41586-021-03777-9","article-title":"Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization","volume":"596","author":"Planas","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.virol.2024.110380_bib47","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41577-020-00479-7","article-title":"A guide to vaccinology: from basic principles to new developments","volume":"21","author":"Pollard","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.virol.2024.110380_bib48","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/nri.2016.94","article-title":"T follicular helper cells in space-time","volume":"16","author":"Qi","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.virol.2024.110380_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvacx.2024.100443","article-title":"Immunogenicity studies of recombinant RBD SARS-CoV-2 as a COVID-19 vaccine candidate produced in Escherichia coli","volume":"16","author":"Safitri","year":"2024","journal-title":"Vaccine X"},{"key":"10.1016\/j.virol.2024.110380_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/biology13040207","article-title":"Influence of mutations and N-glycosylation sites in the receptor-binding domain (RBD) and the membrane protein of SARS-CoV-2 variants of concern on antibody binding in ELISA","volume":"13","author":"Schwarze","year":"2024","journal-title":"Biology"},{"key":"10.1016\/j.virol.2024.110380_bib52","volume":"vol. 4","author":"Seder","year":"2003"},{"key":"10.1016\/j.virol.2024.110380_bib53","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41586-020-2179-y","article-title":"Structural basis of receptor recognition by SARS-CoV-2","volume":"581","author":"Shang","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.virol.2024.110380_bib54","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbaa294","article-title":"AlgPred 2.0: an improved method for predicting allergenic proteins and mapping of IgE epitopes","volume":"22","author":"Sharma","year":"2021","journal-title":"Briefings Bioinf."},{"key":"10.1016\/j.virol.2024.110380_bib55","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.cell.2022.01.015","article-title":"SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron","volume":"185","author":"Tarke","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.virol.2024.110380_bib56","series-title":"Bacterial Endotoxins Test <85>. USP 43-NF 48","year":"2012"},{"key":"10.1016\/j.virol.2024.110380_bib57","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/ni889","article-title":"Lineage relationship and protective immunity of memory CD8T cell subsets","volume":"4","author":"Wherry","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.virol.2024.110380_bib58","author":"WHO"},{"key":"10.1016\/j.virol.2024.110380_bib60","author":"WHO"},{"key":"10.1016\/j.virol.2024.110380_bib61","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkm290","article-title":"ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins","volume":"35","author":"Wiederstein","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.virol.2024.110380_bib62","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.immuni.2011.07.010","article-title":"CD8+ T cells: foot soldiers of the immune system","volume":"35","author":"Zhang","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.virol.2024.110380_bib63","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-021-00653-w","article-title":"Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy","volume":"6","author":"Zhang","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.virol.2024.110380_bib64","unstructured":"Zhu J, Paul WE. CD4 T cells: fates, functions, and faults n.d. https:\/\/doi.org\/10.1182\/blood-2008."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682224004045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682224004045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T13:03:55Z","timestamp":1769951035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682224004045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":62,"alternative-id":["S0042682224004045"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2024.110380","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity of a multivalent protein subunit vaccine based on non-glycosylated RBD antigens of SARS-cov-2 and its variants","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2024.110380","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110380"}}